MDT:NYE-Medtronic plc. (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 90.03

Change

+0.71 (+0.79)%

Market Cap

USD 101.99B

Volume

4.78M

Analyst Target

USD 115.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medtronic PLC is engaged in providing medical technology alleviating pain, restoring health, and extending life of people. It currently functions in four operating segments that manufacture and sell device-based medical therapies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+1.58 (+1.41%)

USD 198.37B
STE STERIS plc

+3.49 (+1.46%)

USD 23.57B
ZBH Zimmer Biomet Holdings Inc

-0.27 (-0.25%)

USD 22.04B
SNN Smith & Nephew SNATS Inc

+0.02 (+0.06%)

USD 13.37B
GMED Globus Medical

+0.93 (+1.32%)

USD 9.55B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.22B
BIO Bio-Rad Laboratories Inc

+2.81 (+0.85%)

USD 9.22B
PEN Penumbra Inc

+2.76 (+1.44%)

USD 7.80B
GKOS Glaukos Corp

+1.99 (+1.55%)

USD 7.05B
INSP Inspire Medical Systems Inc

+8.57 (+4.23%)

USD 6.35B

ETFs Containing MDT

CIB0:XETRA VanEck Bionic Engineering.. 11.14 % 0.00 %

-0.18 (-0.50%)

USD 6.28M
CYBG:LSE VanEck Bionic Engineering.. 9.75 % 0.00 %

-0.22 (-0.50%)

N/A
UMDV:SW iShares US Medical Device.. 9.28 % 0.00 %

N/A

N/A
FLV American Century ETF Trus.. 5.39 % 0.00 %

+0.15 (+-0.50%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

+0.03 (+-0.50%)

N/A
HHL-B:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

-0.03 (-0.50%)

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.03 % 0.00 %

N/A

CAD 0.05B
PCIG Litman Gregory Funds Trus.. 4.80 % 0.00 %

-0.05 (-0.50%)

N/A
ABEQ Absolute Core Strategy ET.. 4.57 % 0.00 %

-0.03 (-0.50%)

USD 0.09B
CAMX Cambiar Aggressive Value .. 4.30 % 0.00 %

-0.06 (-0.50%)

USD 0.06B
XUKS:LSE db x-trackers FTSE 100 Sh.. 4.27 % 0.00 %

+2.93 (+-0.50%)

USD 7.23M
DIVP The Advisors’ Inner .. 3.96 % 0.00 %

+0.05 (+-0.50%)

USD 6.48M
DIVZ Listed Funds Trust - True.. 3.59 % 0.00 %

+0.06 (+-0.50%)

USD 0.12B
AIVL WisdomTree Trust - Wisdom.. 3.47 % 0.00 %

+0.28 (+-0.50%)

USD 0.41B
DXQ:CA Dynamic Active Enhanced Y.. 2.53 % 0.00 %

-0.04 (-0.50%)

N/A
VSDA VictoryShares Dividend Ac.. 2.47 % 0.35 %

+0.08 (+-0.50%)

USD 0.27B
GDVD 2.46 % 0.00 %

N/A

N/A
DVND Touchstone ETF Trust - To.. 2.15 % 0.00 %

+0.06 (+-0.50%)

USD 0.03B
TDOC:CA TD Global Healthcare Lead.. 2.12 % 0.00 %

-0.07 (-0.50%)

CAD 0.09B
QUVU 2.03 % 0.00 %

N/A

N/A
PUD.B:CA 1.85 % 0.66 %

N/A

N/A
CUD:CA iShares US Dividend Growe.. 1.70 % 0.66 %

+0.15 (+-0.50%)

CAD 0.35B
UDVD:LSE SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

-0.56 (-0.50%)

USD 3.76B
USDV:LSE SPDR S&P US Dividend Aris.. 1.69 % 0.00 %

+0.26 (+-0.50%)

USD 3.86B
SPYD:XETRA SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

-0.34 (-0.50%)

USD 3.76B
SPPD:XETRA SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

-0.06 (-0.50%)

USD 0.13B
SPPD:F SSGA SPDR ETFs Europe I p.. 1.69 % 0.00 %

-0.03 (-0.50%)

N/A
USDV:SW SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

-0.07 (-0.50%)

USD 3.84B
REVS Columbia Research Enhance.. 1.53 % 0.00 %

+0.02 (+-0.50%)

USD 0.06B
TWAR 1.11 % 0.00 %

N/A

N/A
VIDI Vident International Equi.. 0.62 % 0.63 %

-0.22 (-0.50%)

USD 0.37B
JIGB 0.45 % 0.14 %

N/A

N/A
VCLT Vanguard Long-Term Corpor.. 0.08 % 0.07 %

-0.25 (-0.50%)

USD 14.05B
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

-0.10 (-0.50%)

USD 35.74B
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

-0.10 (-0.50%)

USD 8.49B
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

-0.27 (-0.50%)

N/A
DTN 0.00 % 0.38 %

N/A

N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.47 (+-0.50%)

N/A
JDIV 0.00 % 0.12 %

N/A

N/A
AIIQ 0.00 % 0.79 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.10 (+-0.50%)

CAD 0.07B
GDNA 0.00 % 0.00 %

N/A

N/A
INAU 0.00 % 0.00 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.11 (-0.50%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.11 (-0.50%)

N/A
SICK 0.00 % 0.95 %

N/A

N/A
YLD Principal Active High Yie.. 0.00 % 0.65 %

-0.07 (-0.50%)

USD 0.23B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
DIVS SmartETFs Dividend Builde.. 0.00 % 0.00 %

-0.13 (-0.50%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.29% 60% D- 54% F
Dividend Return 2.54% 93% A 48% F
Total Return 11.82% 63% D 53% F
Trailing 12 Months  
Capital Gain 15.76% 53% F 48% F
Dividend Return 3.57% 93% A 49% F
Total Return 19.34% 56% F 47% F
Trailing 5 Years  
Capital Gain -15.02% 40% F 25% F
Dividend Return 12.08% 94% A 43% F
Total Return -2.94% 48% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -3.78% N/A N/A 20% F
Dividend Return -1.25% N/A N/A 18% F
Total Return 2.53% N/A N/A 54% F
Risk Return Profile  
Volatility (Standard Deviation) 19.08% N/A N/A 54% F
Risk Adjusted Return -6.58% N/A N/A 20% F
Market Capitalization 101.99B 95% A 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.40 74% 24%
Price/Book Ratio 2.40 52% 35%
Price / Cash Flow Ratio 16.98 47% 21%
Price/Free Cash Flow Ratio 16.33 40% 25%
Management Effectiveness  
Return on Equity 7.95% 77% 51%
Return on Invested Capital 6.09% 64% 52%
Return on Assets 4.42% 74% 70%
Debt to Equity Ratio 47.55% 50% 61%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector